CVALF

OQX Covalon Technologies Ltd.
Nov 21, 2026 · 12:51 AM ET EOD Market Closed

$2.58 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.58, $0.06 below the day’s high of $2.64

YTD change
+108.06%
vs 20-day SMA
-14.08%
vs 200-day SMA
+41.24%

Price ranges

Previous day
$2.58 $2.65
open $2.63 close $2.60
-$0.03 (-1.14%)
Today
$2.58 $2.64
open $2.62 now $2.58
-$0.04 (-1.53%)
Past week
$2.58 $3.03
from $2.93 now $2.58
-$0.35 (-11.91%)
Past month
$2.58 $3.28
from $2.80 now $2.58
-$0.22 (-7.86%)
This year
$1.16 $3.65
from $1.24 now $2.58
+$1.34 (+108.06%)

Price & Performance

+1.09 (+73.15%) / 6M

$1.30$1.99$2.69$3.38May 20Sep 2Nov 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 29.3% away from all-time highs of $3.65
  • CVALF is up 108% since the beginning of the year
  • CVALF is up 86% over the past 12 months
  • CVALF is down 8% over the past 1 month
  • 0% of all CVALF investors are betting against CVALF

CVALF reads poor: price sits above one of the two key moving averages, the 12-month move is +85.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.0721475
Earnings momentum -158.5% Quarterly EPS growth
Quarterly change -158.5%

Valuation

P/E ratio N/A
Enterprise value $59.8M
Beta 1.59

Balance sheet & scale

Income$3.2K
Revenue$24.6M
Cash$13.7M
Debt$1.2K
Income / Debt 2.65×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeOQX
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $71.3M

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $965.00 N/A
GNNSF Genscript Biotech Corporation $3.53 -6.61%
PVLA Palvella Therapeutics, Inc. $142.85 -2.00%
GLXY Galaxy Digital Inc. Class A $11.22 -8.93%
ATGGF Actinogen Medical Limited $0.3300 N/A

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.